Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor Agonists”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT06739044
What this trial is testing

Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 494
Large-scale testing (Phase 3)Looking for participantsNCT07736911
What this trial is testing

Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.

Who this might be right for
GLP-1
Fu Jen Catholic University Hospital 140
Testing effectiveness (Phase 2)Looking for participantsNCT07497399
What this trial is testing

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Johns Hopkins University 120
Not applicableNot Yet RecruitingNCT07130396
What this trial is testing

Impact of Multivitamin (PhytoMulti®) and a Probiotic (UltraFlora® Balance Probiotic) on Gut Health of People Taking GLP-1 Medication

Who this might be right for
GLP-1Adults
Metagenics, Inc. 100
Not applicableUnknownNCT04034524
What this trial is testing

Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Brigham and Women's Hospital 20,000
Early research (Phase 1)Ended earlyNCT05762744
What this trial is testing

Pharmacogenomics of GLP1 Receptor Agonists

Who this might be right for
Type 2 Diabetes
University of Maryland, Baltimore 63
Post-approval studies (Phase 4)Study completedNCT02147925
What this trial is testing

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Sun Yat-sen University 75
Not applicableLooking for participantsNCT07393360
What this trial is testing

Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment

Who this might be right for
Obesity & Overweight
Pharmanutra S.p.a. 144
Not applicableStudy completedNCT07623148
What this trial is testing

GLP-1 RA Cessation and Gastric Ultrasound Findings

Who this might be right for
Residual Gastric ContentsDelayed Gastric Emptying
Wonkwang University Hospital 186
Not applicableNot Yet RecruitingNCT07770737
What this trial is testing

Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cardiovascular DiseasesStage B Heart Failure
Dongtan Sacred Heart Hospital 100
Early research (Phase 1)Ended earlyNCT05694741
What this trial is testing

Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

Who this might be right for
Type 2 Diabetes
AstraZeneca 31
Not applicableStudy completedNCT06154486
What this trial is testing

Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study

Who this might be right for
Pneumonia, AspirationAnesthesia
Hospital Israelita Albert Einstein 30
Not applicableStudy completedNCT06120556
What this trial is testing

Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

Who this might be right for
Diabetes Mellitus, Type 2
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 130
Not applicableLooking for participantsNCT07702461
What this trial is testing

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Obesity & OverweightDiabetes (DM)
Ohio State University 300
Not applicableStudy completedNCT07611201
What this trial is testing

The Effects of GLP-1 Receptor Agonists on Chemosensory Function and Ingestive Behavior

Who this might be right for
ObesityOverweightTaste Perception+3 more
Purdue University 90
Not applicableLooking for participantsNCT07803185
What this trial is testing

Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

Who this might be right for
ObesityEmotional EatingAnhedonia
TC Erciyes University 60
Large-scale testing (Phase 3)Study completedNCT07834398
What this trial is testing

Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes

Who this might be right for
Non-diabetec ObesityObesity (Disorder)
Zagazig University 150
Not applicableNot Yet RecruitingNCT07276763
What this trial is testing

Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention

Who this might be right for
Gastric Retention
Fudan University 16,509
Post-approval studies (Phase 4)Study completedNCT02291874
What this trial is testing

Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 100
Post-approval studies (Phase 4)Active Not RecruitingNCT06908694
What this trial is testing

Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
Hamilton Health Sciences Corporation 20
Next Page